Michael S. Perry
Director · ARROWHEAD PHARMACEUTICALS, INC.
IndividualSelling only
- 2024
- Aug 20, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael S. Perry files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Richard Anzalone - $12.35M in ARWR purchases and sales in the last 12 months
- James C. Hamilton - $1.39M in ARWR purchases and sales in the last 12 months
- Daniel Joseph Apel - $934K in ARWR purchases and sales in the last 12 months
- Mauro Ferrari - $493K in ARWR purchases and sales in the last 12 months
- Hongbo Lu - $228K in ARWR purchases and sales in the last 12 months
- Adeoye Y. Olukotun - $174K in ARWR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael S. Perry?
Michael S. Perry is a corporate insider, tracked as Director of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael S. Perry submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael S. Perry been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.01M) across all tracked filings.
